Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FARM
11926
PUT
DELISTED
Farmer Brothers
FARM
| $40.2K | ﹤0.01% |
+18,100
| New | +$39K |
|
|
BTLN
11927
Brightline Interactive
BTLN
$21.3M
| $40.2K | ﹤0.01% |
34,619
-83,684
| -71% | -$137K |
|
11928
PUT
Tempest Therapeutics
TPST
$18.4M
| $40K | ﹤0.01% |
4,154
-2,331
| -36% | -$26.4K |
|
11929
RAVE Restaurant Group
RAVE
$44.6M
| $39.8K | ﹤0.01% |
+14,466
| New | +$38.7K |
|
|
RPTX
11930
DELISTED
Repare Therapeutics
RPTX
| $39.5K | ﹤0.01% |
+40,096
| New | +$48.3K |
|
11931
Braskem
BAK
$602M
| $39.5K | ﹤0.01% |
+10,260
| New | +$42.6K |
|
11932
FTC Solar
FTCI
$35.2M
| $39.4K | ﹤0.01% |
+13,737
| New | +$48.3K |
|
11933
CALL
Outdoor Holding Co
POWW
$258M
| $39.3K | ﹤0.01% |
+28,500
| New | +$44.2K |
|
11934
PUT
Beam Global
BEEM
$30.9M
| $39.2K | ﹤0.01% |
19,200
-2,100
| -10% | -$5.41K |
|
11935
CALL
X4 Pharmaceuticals
XFOR
$413M
| $39K | ﹤0.01% |
5,423
-2,360
| -30% | -$32.5K |
|
11936
Grove Collaborative
GROV
$41.4M
| $39K | ﹤0.01% |
28,887
-1,520
| -5% | -$2.35K |
|
|
AXDX
11937
DELISTED
Accelerate Diagnostics
AXDX
| $38.7K | ﹤0.01% |
55,268
+25,616
| +86% | +$29.2K |
|
11938
Pixelworks
PXLW
$42.3M
| $38.6K | ﹤0.01% |
5,137
-5,273
| -51% | -$48.5K |
|
11939
PUT
Rekor Systems
REKR
$80.8M
| $38.6K | ﹤0.01% |
43,400
-10,100
| -19% | -$15.9K |
|
11940
CALL
Sight Sciences
SGHT
$461M
| $38.4K | ﹤0.01% |
16,000
-12,000
| -43% | -$33.8K |
|
11941
TechPrecision Corp
TPCS
$57.9M
| $38.3K | ﹤0.01% |
+16,662
| New | +$49K |
|
11942
Good Times Restaurants
GTIM
$15.6M
| $38.3K | ﹤0.01% |
15,574
-50,195
| -76% | -$124K |
|
11943
Optical Cable Corp
OCC
$117M
| $38.2K | ﹤0.01% |
13,704
+680
| +5% | +$2.91K |
|
|
EU
11944
PUT
enCore Energy
EU
$274M
| $38.2K | ﹤0.01% |
27,900
-6,800
| -20% | -$17.5K |
|
11945
Marker Therapeutics
MRKR
$25.3M
| $38.2K | ﹤0.01% |
+31,027
| New | +$56.8K |
|
11946
AXT Inc
AXTI
$4.33B
| $38K | ﹤0.01% |
26,931
-203,120
| -88% | -$388K |
|
|
WW
11947
PUT
DELISTED
WW International
WW
| $38K | ﹤0.01% |
73,000
-626,900
| -90% | -$545K |
|
11948
ZW Data Action Technologies
CNET
$5.17M
| $37.8K | ﹤0.01% |
25,536
+14,174
| +125% | +$23K |
|
11949
Creative Realities
CREX
$38.3M
| $37.6K | ﹤0.01% |
+19,272
| New | +$44.5K |
|
|
MAXN
11950
PUT
DELISTED
Maxeon Solar Technologies
MAXN
| $37.5K | ﹤0.01% |
12,700
-107,600
| -89% | -$546K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.